Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 5, pp. 617-627
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 27, 2017
- Revision received January 9, 2018
- Accepted February 22, 2018
- Published first February 26, 2018.
Article Versions
- Previous version (February 26, 2018 - 07:40).
- Previous version (February 27, 2018 - 07:18).
- Previous version (April 9, 2018 - 07:52).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Hussein Sultan1,
- Takumi Kumai2,3,4,
- Valentyna I. Fesenkova1,
- Aaron E. Fan1,
- Juan Wu1,
- Hyun-Il Cho5,
- Hiroya Kobayashi2,
- Yasuaki Harabuchi3, and
- Esteban Celis1,*
- 1Cancer Immunology, Inflammation and Tolerance Program, Augusta University Georgia Cancer Center, Augusta, Georgia.
- 2Department of Pathology, Asahikawa Medical University, Asahikawa, Japan.
- 3Department of Otolaryngology, Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan.
- 4Department of Innovative Research for Diagnosis and Treatment of Head and Neck Cancer, Asahikawa Medical University, Asahikawa, Japan.
- 5Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea.
- ↵*Corresponding Author:
Esteban Celis, Augusta University, 1410 Laney Walker Boulevard, CN4121, Augusta, GA 30912. Phone: 706-721-5668; Fax: 706-721-1670; E-mail: ecelis{at}augusta.edu
H. Sultan, T. Kumai, and V.I. Fesenkova contributed equally to this article.
May 2018
Volume 6, Issue 5
Volume 6, Issue 5
Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
Jump to section
Advertisement